📈 Will you get serious about investing in 2025? Take the first step with 50% off InvestingProClaim Offer

BMO cuts Target price target to $120 from $160

Published 21/11/2024, 17:34
BMO cuts Target price target to $120 from $160
TGT
-

On Thursday, BMO Capital Markets adjusted its outlook on Target Corporation (NYSE:TGT), reducing the retailer's price target to $120 from the previous $160. The firm has retained its Market Perform rating on the stock. The revision follows Target's third-quarter earnings, which did not meet the expectations set by BMO Capital.

The earnings report highlighted several challenges for Target, including declining comparable store sales, which suggest potential market share losses. Additionally, the company is experiencing renewed pressures in digital sales and supply chain margins, particularly with the increase in ship-to-home orders. These factors contributed to the analyst's decision to reduce the price target.

BMO Capital's analysis indicates that these recent developments may have longer-term implications for Target's supply chain operations. The updated price target of $120 reflects a 12 to 13 times multiple on the firm's forecasted fiscal year 2027 earnings per share (EPS), which is lower than Target's historical average valuation of 15 times but remains above the 10 times multiple seen at trough levels.

The commentary from BMO Capital underscores the ongoing concerns regarding lean inventories and the shift in channel mix, which were previously anticipated to diminish. The weaker-than-expected quarterly performance has led to a reassessment of Target's financial prospects.

In light of these factors, BMO Capital has recalibrated its earnings per share estimates for Target, aligning them with the revised valuation multiples and the current market dynamics. The firm's stance on Target remains cautious, with a watchful eye on the retailer's ability to navigate the complex retail environment and supply chain challenges ahead.

In other recent news, Target Corporation faced multiple adjustments from financial firms following its recent third-quarter earnings results. TD Cowen lowered the stock's price target from $165 to $145, maintaining a Hold rating, citing areas where the retailer needs to improve. Similarly, Jefferies revised its price target for Target to $165, despite maintaining a Buy rating, following third-quarter results that fell short of consensus expectations.

Piper Sandler also adjusted its price target for Target to $130 from $156, maintaining a Neutral rating in light of Target's third-quarter earnings miss. DA Davidson, while expressing caution about the consumer spending environment, lowered the price target for Target to $150 but maintained a Buy rating. Evercore ISI reduced its price target for Target from $165 to $130, maintaining an In Line rating, after noting a 4.5% decline in two-year comparable sales and a 60 basis point squeeze on EBIT margins.

Despite these adjustments, Target reported some positive developments, including a 6% increase in beauty category sales, an 11% rise in digital sales, and a 50% year-to-date increase in free cash flow.

InvestingPro Insights

Recent data from InvestingPro sheds additional light on Target's current financial situation and market performance. The company's stock has experienced significant downward pressure, with a 20.11% decline in the past week and a 23.01% drop over the last three months. This aligns with BMO Capital's cautious stance and reduced price target.

Despite these challenges, InvestingPro Tips highlight some positive aspects of Target's financial profile. The company has maintained dividend payments for 54 consecutive years, demonstrating a commitment to shareholder returns even in challenging times. Additionally, Target's P/E ratio of 16.54 and forward P/E of 12.23 suggest the stock may be undervalued relative to its earnings potential, especially considering its PEG ratio of 0.38.

For investors seeking a more comprehensive analysis, InvestingPro offers 13 additional tips on Target, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.